Standard Process FAQ

Standard Process sits in the practitioner-channel whole-food concentrate niche alongside Biotics Research and Apex Energetics, distinct from the bioidentical-isolate practitioner-channel brands (Thorne, Pure Encapsulations, Designs for Health). The clinical case for Standard Process formulas is strongest in patients where the cofactor-matrix preservation matters more than the absolute milligram delivery — older adults with reduced enzyme cofactor availability, patients with multiple co-occurring micronutrient gaps, and patients where the methodology of low-dose continuous support fits the protocol better than periodic megadose isolates.

The premise is that nutrients embedded in a whole-food matrix bring their cofactors with them — bioflavonoids supporting vitamin C absorption, the natural mixed tocopherol family supporting vitamin E function, the nutritional-yeast B-vitamin matrix supporting cofactor regeneration. The clinical observation that supports this framing is the differential subjective and lab response some patients show to whole-food multi-vitamin protocols versus equivalent-dose synthetic multi-vitamin protocols. Mechanistic evidence is strong; head-to-head RCT evidence is thinner than the marketing implies.

Protomorphogen extracts and glandular concentrates are mechanistically unusual — bovine organ tissue and nuclear material at low doses on the autoimmune-tissue-support theory developed by Dr. Royal Lee in the 1940s. Clinical evidence is largely empirical rather than RCT-supported. The practical patient-selection considerations are: autoimmune thyroid disease (relative contraindication for Thytrophin PMG and broader PMG line), known beef allergy (absolute contraindication for any glandular or PMG product), and active autoimmune conditions broadly (warrant explicit rheumatology or specialist coordination).

Functionally, the program is a structured 21-day caloric-restriction protocol with whole-food shake-based meal replacement, plus a defined supplement stack supporting phase-1 and phase-2 hepatic biotransformation. The clinical evidence base for periodic 'cleansing' as a discrete intervention is mixed; what the program does effectively is enforce a 21-day structured eating-pattern reset with practitioner accountability. Patient selection matters — pregnancy, lactation, eating-disorder history, advanced CKD, and significant hepatic disease are exclusions. Hepatology coordination is warranted for any patient with established hepatic concern.

Patients with multiple low-grade micronutrient gaps where the methodology of low-dose continuous whole-food concentrate support fits the clinical picture; older adults whose digestive cofactor availability is reduced; patients with documented sensitivity to common synthetic-isolate excipients (magnesium stearate, titanium dioxide, synthetic colorants); patients in cardiovascular or adrenal protocols where the broader Cataplex and glandular stack has a clinical track record; integrative medicine patients participating in the 21-Day Purification Program under practitioner supervision.

The glandular and PMG line in patients with thyroid disease — TSH, free T4, and thyroid antibody panel before initiation and at 12 weeks. The cardiovascular formulas (Cardio-Plus, Cataplex E) in patients on statins — lipid panel monitoring. The MediHerb diuretic-acting formulas (Cornsilk Complex, Renaltrophin PMG) in patients on lithium — lithium-level monitoring. Any green-vegetable concentrate or chlorophyll formula in patients on warfarin — INR monitoring. The 21-Day Purification Program in any patient with hepatic concern — AST/ALT and ammonia coverage.

Apex Energetics is the closest peer — also practitioner-channel, also whole-food and herbal forward, with a stronger gluten-and-autoimmune-protocol focus and a less farm-integrated supply chain. Designs for Health is practitioner-channel but bioidentical-isolate-forward (closer to Thorne and Pure Encapsulations philosophically) and typically lower price-per-serving than Standard Process. Biotics Research is the closest competitor on glandular and protomorphogen-adjacent products. The Standard Process differentiator across the peer group is the 95-year operating history plus the vertically-integrated Palmyra farm.

A practitioner-written Standard Process brand review covers the catalog category by category with functional-medicine-relevant patient selection, lab monitoring, and patient-profile-fit discussion for each major product line.